These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30862304)

  • 1.
    Lopes LL; Bressan J; Peluzio MDCG; Hermsdorff HHM
    J Am Coll Nutr; 2019 Jul; 38(5):478-484. PubMed ID: 30862304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A haplotype of the ANGPTL3 gene is associated with CVD risk, diabetes mellitus, hypertension, obesity, metabolic syndrome, and dyslipidemia.
    Aghasizadeh M; Zare-Feyzabadi R; Kazemi T; Avan A; Ferns GA; Esmaily H; Miri-Moghaddam E; Ghayour-Mobarhan M
    Gene; 2021 May; 782():145525. PubMed ID: 33636293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic processing in cardiometabolic disease.
    Costantino S; Mohammed SA; Ambrosini S; Paneni F
    Atherosclerosis; 2019 Feb; 281():150-158. PubMed ID: 30290963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylation and Hydroxymethylation Levels in Relation to Two Weight Loss Strategies: Energy-Restricted Diet or Bariatric Surgery.
    Nicoletti CF; Nonino CB; de Oliveira BA; Pinhel MA; Mansego ML; Milagro FI; Zulet MA; Martinez JA
    Obes Surg; 2016 Mar; 26(3):603-11. PubMed ID: 26198618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiometabolic syndrome in persons of the African diaspora: challenges and opportunities.
    Schuster DP; Gaillard T; Osei K
    J Cardiometab Syndr; 2007; 2(4):260-6. PubMed ID: 18059209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation markers in obesity, metabolic syndrome, and weight loss.
    Samblas M; Milagro FI; Martínez A
    Epigenetics; 2019 May; 14(5):421-444. PubMed ID: 30915894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic reticulum stress epigenetics is related to adiposity, dyslipidemia, and insulin resistance.
    Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Moreno-Aliaga MJ; Martinez JA;
    Adipocyte; 2018; 7(2):137-142. PubMed ID: 29570038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accounting for Life-Course Exposures in Epigenetic Biomarker Association Studies: Early Life Socioeconomic Position, Candidate Gene DNA Methylation, and Adult Cardiometabolic Risk.
    Huang JY; Gavin AR; Richardson TS; Rowhani-Rahbar A; Siscovick DS; Hochner H; Friedlander Y; Enquobahrie DA
    Am J Epidemiol; 2016 Oct; 184(7):520-531. PubMed ID: 27651384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes mellitus and cardiovascular risk; what the pharmacotherapy can change through the epigenetics.
    Andreeva-Gateva PA; Mihaleva ID; Dimova II
    Postgrad Med; 2020 Mar; 132(2):109-125. PubMed ID: 31615302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic inflexibility in skeletal muscle: a prelude to the cardiometabolic syndrome?
    Thyfault JP; Rector RS; Noland RC
    J Cardiometab Syndr; 2006; 1(3):184-9. PubMed ID: 17679820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Mechanisms of Vascular Dysfunction in Cardiometabolic Patients: Focus on Epigenetics.
    Ambrosini S; Mohammed SA; Lüscher TF; Costantino S; Paneni F
    High Blood Press Cardiovasc Prev; 2020 Oct; 27(5):363-371. PubMed ID: 32740853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation signatures associated with cardiometabolic risk factors in children from India and The Gambia: results from the EMPHASIS study.
    Antoun E; Issarapu P; di Gravio C; Shrestha S; Betts M; Saffari A; Sahariah SA; Sankareswaran A; Arumalla M; Prentice AM; Fall CHD; Silver MJ; Chandak GR; Lillycrop KA;
    Clin Epigenetics; 2022 Jan; 14(1):6. PubMed ID: 35000590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dynamic Platelet Transcriptome in Obesity and Weight Loss.
    Ezzaty Mirhashemi M; Shah RV; Kitchen RR; Rong J; Spahillari A; Pico AR; Vitseva O; Levy D; Demarco D; Shah S; Iafrati MD; Larson MG; Tanriverdi K; Freedman JE
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):854-864. PubMed ID: 33297754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of SOCS3 is inversely associated with metabolic syndrome in an epigenome-wide association study of obesity.
    Ali O; Cerjak D; Kent JW; James R; Blangero J; Carless MA; Zhang Y
    Epigenetics; 2016 Sep; 11(9):699-707. PubMed ID: 27564309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease and modifiable cardiometabolic risk factors.
    Cannon CP
    Clin Cornerstone; 2007; 8(3):11-28. PubMed ID: 18452839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Vitamin B12 and Lipid Metabolism: Evidence from Pre-Clinical and Clinical Studies.
    Boachie J; Adaikalakoteswari A; Samavat J; Saravanan P
    Nutrients; 2020 Jun; 12(7):. PubMed ID: 32610503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Recent Update on the Epigenetic Repertoire and Chromatin Modifying Therapy in Diabetes Mellitus: A Comprehensive Review.
    Wang X; Zhao D; Beeraka NM; Tatineni S; Sri CD; Nishanth VV; Uthiah CA; Leihang Z; Sugur K; Liu J; Nikolenko VN; Fan R
    Curr Med Chem; 2023; 30(18):2020-2038. PubMed ID: 35927905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic priming of the metabolic syndrome.
    Bruce KD; Cagampang FR
    Toxicol Mech Methods; 2011 May; 21(4):353-61. PubMed ID: 21495873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epigenetic signature of systemic insulin resistance in obese women.
    Arner P; Sahlqvist AS; Sinha I; Xu H; Yao X; Waterworth D; Rajpal D; Loomis AK; Freudenberg JM; Johnson T; Thorell A; Näslund E; Ryden M; Dahlman I
    Diabetologia; 2016 Nov; 59(11):2393-2405. PubMed ID: 27535281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.